| 发明名称 |
ANTI-TUMORAL COMPOSITION COMPRISING THE COMPOUND 1-(6--1,3-BENZOTHIAZOL-2-YL)-3-(2-MORPHOLIN-4-YLETHYL)UREA |
| 摘要 |
The present invention concerns an anti-tumoral composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea and its use in the treatment of cancer. |
| 申请公布号 |
US2015119391(A1) |
申请公布日期 |
2015.04.30 |
| 申请号 |
US201514593059 |
申请日期 |
2015.01.09 |
| 申请人 |
SANOFI |
发明人 |
AUTHELIN Jean-Rene;BENARD Tsiala;MATHIEU Amandine;PERACCHIA Maria-Teresa;GOULAOUIC Helene;ASSADOURIAN Sylvie |
| 分类号 |
A61K47/40;A61K9/08;A61K31/5377 |
主分类号 |
A61K47/40 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A concentrated liquid aqueous pharmaceutical composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea, or a pharmaceutically acceptable salt thereof, and a cyclodextrin. |
| 地址 |
Paris FR |
